Opportunities and challenges of PROTAC in the treatment of protein-driven diseases
Targeted protein degradation (TPD) has transformed the landscape of drug discovery by exploiting the ubiquitin-proteasome system (UPS) to eliminate, rather than inhibit, pathogenic proteins. This paradigm shift enables access to a vast array of previously “undruggable” targets and offers new therape...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2026-05-01
|
| Col·lecció: | Results in Chemistry |
| Matèries: | |
| Accés en línia: | http://www.sciencedirect.com/science/article/pii/S2211715626002079 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
